Article
SCN8A epileptic encephalopathy mutations display a gain-of-function phenotype and divergent sensitivity to antiepileptic drugs.
Acta pharmacologica Sinica - 1 Dec 2022
Guo Qian-Bei, Zhan Li, Xu Hai-Yan, Gao Zhao-Bing, Zheng Yue-Ming
Abstract excerpt
De novo missense mutations in SCN8A gene encoding voltage-gated sodium channel NaV1.6 are linked to a severe form of early infantile epileptic encephalopathy named early infantile epileptic encephalopathy type13 (EIEE13). The majority of the patients with EIEE13 does not respond favorably to the antiepileptic drugs (AEDs) in clinic and has a significantly increased risk of death. Although more than 60...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
